Cyclacel Pharmaceuticals, Inc. - Common Stock (NQ:CYCC)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 6.365 |
| Bid (Size) | 6.210 (1) |
| Ask (Size) | 6.440 (1) |
| Prev. Close | 6.365 |
| Today's Range | 6.365 - 6.365 |
| 52wk Range | 6.365 - 6.365 |
| Shares Outstanding | 4,900,142 |
| Dividend Yield | 2.36% |
Top News
More News
Performance
More News
Read More
Thursday's session: gap up and gap down stocks ↗
July 24, 2025
Top stock movements in today's session. ↗
July 18, 2025
Friday's session: top gainers and losers ↗
July 18, 2025
US Stocks Mixed; Bank of America Earnings Top Views ↗
July 16, 2025
Frequently Asked Questions
Is Cyclacel Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Cyclacel Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Cyclacel Pharmaceuticals, Inc. - Common Stock trade on?
Cyclacel Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cyclacel Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Cyclacel Pharmaceuticals, Inc. - Common Stock is CYCC on the Nasdaq Stock Market
What is the current price of Cyclacel Pharmaceuticals, Inc. - Common Stock?
The current price of Cyclacel Pharmaceuticals, Inc. - Common Stock is 6.365
When was Cyclacel Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Cyclacel Pharmaceuticals, Inc. - Common Stock was at 09/11/25 04:00 PM ET
What is the market capitalization of Cyclacel Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Cyclacel Pharmaceuticals, Inc. - Common Stock is 31.19M
How many shares of Cyclacel Pharmaceuticals, Inc. - Common Stock are outstanding?
Cyclacel Pharmaceuticals, Inc. - Common Stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.